Correction to: An RBD-Fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters (npj Vaccines, (2025), 10, 1, (100), 10.1038/s41541-025-01155-4)

Yanjun Zhang; Yan Wu; Meng Qian Zhang; Haiyue Rao; Zhaoyong Zhang; Xiangyue He; Yiwen Liang; Raoqing Guo; Yaochang Yuan; Jing Sun; Helen M.E. Duyvesteyn; Elizabeth E. Fry; David I. Stuart; Jingxian Zhao; Xiao Yan Pan; Shu Lin Liu; Jincun Zhao; Jiandong Huo

ArticleOPEN ACCESS

Correction to: An RBD-Fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters (npj Vaccines, (2025), 10, 1, (100), 10.1038/s41541-025-01155-4)

npj Vaccines

DOI: 10.1038/s41541-025-01210-0

0Citations

N/AReaders

Abstract

Correction to:npj Vaccineshttps://doi.org/10.1038/s41541-025-01155-4, published online 18 May 2025 “In this article, the legends to Figure 4, Figure 6 and Figure 7 incorrectly mentioned SARS-CoV-2 KP.3 but should have been SARS-CoV-2 XBB.1. The original article has been corrected.”

Cite

CITATION STYLE

APA

Zhang, Y., Wu, Y., Zhang, M. Q., Rao, H., Zhang, Z., He, X., … Huo, J. (2025, December 1). Correction to: An RBD-Fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters (npj Vaccines, (2025), 10, 1, (100), 10.1038/s41541-025-01155-4). Npj Vaccines. Nature Research. https://doi.org/10.1038/s41541-025-01210-0

Correction to: An RBD-Fc mucosal vaccine provides variant-proof protection against SARS-CoV-2 in mice and hamsters (npj Vaccines, (2025), 10, 1, (100), 10.1038/s41541-025-01155-4)

Abstract

Cite

Register to see more suggestions